MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, DRMAW has $7,863,826 in assets. $1,640,446 in debts. $7,521,978 in cash and cash equivalents.

Balance Sheets Overview

Debt to Asset Ratio
20.86%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable (including rela...
    • Common stock, par value 0.0001, ...

Balance Sheets
2025-12-31
Cash and cash equivalents
7,521,978
Prepaid expenses and other current assets
341,848
Total assets
7,863,826
Accounts payable (including related party amounts of 86,250 and 0, respectively)
460,811
Accrued and other current liabilities (including related party amounts of 25,000 and 0, respectively)
1,179,635
Total liabilities
1,640,446
Common stock, par value 0.0001, 250,000,000 shares authorized as of december 31, 2025, and 2024 2,660,110 and 251,725 shares issued and outstanding as of december 31, 2025, and 2024, respectively
266
Additional paid-in capital
79,457,010
Accumulated deficit
-73,233,896
Total stockholders equity
6,223,380
Total liabilities and stockholders equity
7,863,826
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$7,521,978 Prepaid expenses andother current assets$341,848 Total assets$7,863,826 Total liabilities andstockholders equity$7,863,826 Total stockholdersequity$6,223,380 Total liabilities$1,640,446 Accumulated deficit-$73,233,896 Additional paid-in capital$79,457,010 Accrued and othercurrent liabilities...$1,179,635 Accounts payable(including related party...$460,811 Common stock, par value0.0001, 250,000,000...$266

Dermata Therapeutics, Inc. (DRMAW)

Dermata Therapeutics, Inc. (DRMAW)